Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4

Cancer Gene Therapy, Published online: 15 July 2022; doi:10.1038/s41417-022-00501-1Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Source Type: research